國立虎尾科技大學 |

Resistance of Cancer Cells to CTL-Mediated Immunotherapy

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Resistance of Cancer Cells to CTL-Mediated Immunotherapy/ edited by Benjamin Bonavida, Salem Chouaib.
other author:	Bonavida, Benjamin.
Description:	XIX, 353 p. 38 illus., 27 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Cancer research. -
Online resource:	https://doi.org/10.1007/978-3-319-17807-3
ISBN:	9783319178073

Resistance of Cancer Cells to CTL-Mediated Immunotherapy
Resistance of Cancer Cells to CTL-Mediated Immunotherapy[electronic resource] /edited by Benjamin Bonavida, Salem Chouaib. - 1st ed. 2015. - XIX, 353 p. 38 illus., 27 illus. in color.online resource. - Resistance to Targeted Anti-Cancer Therapeutics,72196-5501 ;. - Resistance to Targeted Anti-Cancer Therapeutics,4.

This book, written by leading investigators, brings together the latest knowledge about key aspects of the most rapidly progressing fields of tumor escape and tumor resistance to CTL. Readers will benefit from a collection of outstanding surveys that cover some factors regulating resistance to CTL cytotoxicity, the influence of tumor microenvironment, and the resistance to death ligands, mediated apoptosis, and means to reverse resistance. This remarkable volume also emphasizes the future directions that may lead to the design of more innovative, refined, and integrative immunotherapies to target tumor plasticity and heterogeneity, and help to overcome the inherent limitations of current treatments. By providing a broad scope of innovative concepts in the burgeoning field of cancer biology and immunotherapy, this volume will be of exceptional interest and a valuable reference for scientists, clinicians, health professionals, and biopharmaceutical companies working in the field of cancer immunotherapy. .

ISBN: 9783319178073

Standard No.: 10.1007/978-3-319-17807-3doiSubjects--Topical Terms:

1253664
Cancer research.

LC Class. No.: RC261-271

Dewey Class. No.: 614.5999

Resistance of Cancer Cells to CTL-Mediated Immunotherapy
LDR:02483nam a22003975i 4500 001 969818
003 DE-He213
005 20200703085038.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319178073 $9 978-3-319-17807-3
024 7 $a 10.1007/978-3-319-17807-3 $2 doi
035 $a 978-3-319-17807-3
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
245 1 0 $a Resistance of Cancer Cells to CTL-Mediated Immunotherapy $h [electronic resource] / $c edited by Benjamin Bonavida, Salem Chouaib.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a XIX, 353 p. 38 illus., 27 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Resistance to Targeted Anti-Cancer Therapeutics, $x 2196-5501 ; $v 7
520 $a This book, written by leading investigators, brings together the latest knowledge about key aspects of the most rapidly progressing fields of tumor escape and tumor resistance to CTL. Readers will benefit from a collection of outstanding surveys that cover some factors regulating resistance to CTL cytotoxicity, the influence of tumor microenvironment, and the resistance to death ligands, mediated apoptosis, and means to reverse resistance. This remarkable volume also emphasizes the future directions that may lead to the design of more innovative, refined, and integrative immunotherapies to target tumor plasticity and heterogeneity, and help to overcome the inherent limitations of current treatments. By providing a broad scope of innovative concepts in the burgeoning field of cancer biology and immunotherapy, this volume will be of exceptional interest and a valuable reference for scientists, clinicians, health professionals, and biopharmaceutical companies working in the field of cancer immunotherapy. .
650 0 $a Cancer research. $3 1253664
650 0 $a Drug resistance. $3 872072
650 0 $a Molecular biology. $3 583443
650 1 4 $a Cancer Research. $3 668358
650 2 4 $a Drug Resistance. $3 782695
650 2 4 $a Molecular Medicine. $3 668353
700 1 $a Bonavida, Benjamin. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 681916
700 1 $a Chouaib, Salem. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1265375
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319178080
776 0 8 $i Printed edition: $z 9783319178066
776 0 8 $i Printed edition: $z 9783319380674
830 0 $a Resistance to Targeted Anti-Cancer Therapeutics, $x 2196-5501 ; $v 4 $3 1254768
856 4 0 $u https://doi.org/10.1007/978-3-319-17807-3
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)